Loading clinical trials...
Loading clinical trials...
Accuracy of Markerless Motion Analysis in Comparison With Optoelectronic Motion Capture System
The purpose of this study was to assess the Openpose reliability to measure kinematics and spatiotemporal gait parameters and to evaluate the minimum technical requirements. This analysis used video and optoelectronic motion capture simultaneously recorded. We assessed more of 20 subject with different motor gait impairments
Marker-based Optical motion tracking is the gold standard in gait analysis, but today, markerless solutions are growing rapidly. Treatment of physical impairments could improve if supported with reliable motion capture. Moreover, the use of markerless technology offers numerous advantages for working with pediatric populations under various conditions. In this paper, we assess the Openpose reliability to measure kinematics and spatiotemporal gait parameters and to evaluate the minimum technical requirements., in a population of children with and without gait impairments. Validating markerless methods can open the way for new motion capture techniques and enhance the accessibility of kinematic measurements and improve the treatment of physical impairments.
Age
4 - 65 years
Sex
ALL
Healthy Volunteers
Yes
IRCCS E. Medea
Bosisio Parini, Italy, Italy
Start Date
May 15, 2024
Primary Completion Date
September 24, 2026
Completion Date
September 24, 2026
Last Updated
February 27, 2026
25
ACTUAL participants
Measure gait spatiotemporal parameters and kinematics from optoelectronic system
OTHER
Measure gait spatiotemporal parameters and kinematics from markerless system
OTHER
Quantify tip toe step during gait from kinematic
OTHER
Lead Sponsor
IRCCS Eugenio Medea
NCT07095062
NCT06521918
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06642454